Chemoinformaics analysis of Oxacyclotetradecan-2-one
Molecular Weight | 212.333 | nRot | 0 |
Heavy Atom Molecular Weight | 188.141 | nRig | 30 |
Exact Molecular Weight | 212.178 | nRing | 1 |
Solubility: LogS | -3.944 | nHRing | 1 |
Solubility: LogP | -0.446 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 39.317 |
nHD | 0 | BPOL | 26.681 |
QED | 0.159 |
Synth | 4.675 |
Natural Product Likeliness | 2.173 |
NR-PPAR-gamma | 0.935 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.967 |
HIA | 0.89 |
CACO-2 | -6.293 |
MDCK | 0.0000444 |
BBB | 0.161 |
PPB | 0.832165 |
VDSS | 0.736 |
FU | 0.200737 |
CYP1A2-inh | 0.013 |
CYP1A2-sub | 0.026 |
CYP2c19-inh | 0.01 |
CYP2c19-sub | 0.056 |
CYP2c9-inh | 0.002 |
CYP2c9-sub | 0.445 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.155 |
CYP3a4-inh | 0.015 |
CYP3a4-sub | 0.008 |
CL | 1.29 |
T12 | 0.445 |
hERG | 0.014 |
Ames | 0.76 |
ROA | 0.066 |
SkinSen | 0.019 |
Carcinogencity | 0.136 |
EI | 0.006 |
Respiratory | 0.014 |
NR-Aromatase | 0.953 |
Antiviral | Yes |
Prediction | 0.792242 |